These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. Haslett PA; Nixon DF; Shen Z; Larsson M; Cox WI; Manandhar R; Donahoe SM; Kaplan G J Infect Dis; 2000 Apr; 181(4):1264-72. PubMed ID: 10751137 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients. Papasavvas E; Foulkes A; Yin X; Joseph J; Ross B; Azzoni L; Kostman JR; Mounzer K; Shull J; Montaner LJ Immunology; 2015 Jul; 145(3):380-90. PubMed ID: 25684333 [TBL] [Abstract][Full Text] [Related]
8. HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption. Papasavvas E; Kostman JR; Thiel B; Pistilli M; Mackiewicz A; Foulkes A; Gross R; Jordan KA; Nixon DF; Grant R; Poulin JF; McCune JM; Mounzer K; Montaner LJ J Clin Immunol; 2006 Jan; 26(1):40-54. PubMed ID: 16418802 [TBL] [Abstract][Full Text] [Related]
9. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals. Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458 [TBL] [Abstract][Full Text] [Related]
10. Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea. López M; Benito JM; Lozano S; Barreiro P; Martínez P; González-Lahoz J; Soriano V AIDS; 2004 Jun; 18(9):1251-61. PubMed ID: 15362657 [TBL] [Abstract][Full Text] [Related]
11. Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals. Clarridge KE; Blazkova J; Einkauf K; Petrone M; Refsland EW; Justement JS; Shi V; Huiting ED; Seamon CA; Lee GQ; Yu XG; Moir S; Sneller MC; Lichterfeld M; Chun TW PLoS Pathog; 2018 Jan; 14(1):e1006792. PubMed ID: 29324842 [TBL] [Abstract][Full Text] [Related]
12. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection. Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527 [TBL] [Abstract][Full Text] [Related]
13. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030 [TBL] [Abstract][Full Text] [Related]
14. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575 [TBL] [Abstract][Full Text] [Related]
15. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Ortiz GM; Wellons M; Brancato J; Vo HT; Zinn RL; Clarkson DE; Van Loon K; Bonhoeffer S; Miralles GD; Montefiori D; Bartlett JA; Nixon DF Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13288-93. PubMed ID: 11687611 [TBL] [Abstract][Full Text] [Related]
16. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. Daucher M; Price DA; Brenchley JM; Lamoreaux L; Metcalf JA; Rehm C; Nies-Kraske E; Urban E; Yoder C; Rock D; Gumkowski J; Betts MR; Dybul MR; Douek DC J Virol; 2008 Apr; 82(8):4102-14. PubMed ID: 18234797 [TBL] [Abstract][Full Text] [Related]
17. Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection. Connick E; Bosch RJ; Aga E; Schlichtemeier R; Demeter LM; Volberding P; J Acquir Immune Defic Syndr; 2011 Sep; 58(1):1-8. PubMed ID: 21637110 [TBL] [Abstract][Full Text] [Related]
18. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. García F; Plana M; Ortiz GM; Bonhoeffer S; Soriano A; Vidal C; Cruceta A; Arnedo M; Gil C; Pantaleo G; Pumarola T; Gallart T; Nixon DF; Miró JM; Gatell JM AIDS; 2001 Jun; 15(9):F29-40. PubMed ID: 11416735 [TBL] [Abstract][Full Text] [Related]
19. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]